InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Keyes Jeffry R., Director. Director active across 3 companies, notably CNS Pharmaceuticals, Inc.. Cumulatively, 10 filings have been logged. Split: 2 buys · 3 sells. Total volume traded: €125k. History available since 7 March 2022. The latest transaction was filed on 21 March 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
10 of 10 declarations
Jeffry R. Keyes serves as a Director at CNS Pharmaceuticals, Inc. In this role, he participates in the governance of the company and strategic decision-making. His experience in the pharmaceutical sector and knowledge of CNS's operations allow him to provide valuable insights during board meetings. He is committed to supporting the company's mission and objectives.